Psoriasis is a chronic skin disease that affects millions of people throughout the world. Even
though cutaneous signs and symptoms are the most common clinical manifestations, the …

Nail involvement in psoriasis is common, and the severity of it does not always parallel the
intensity of cutaneous disease. We created a consensus group, of which the aim was to …

Abstract Nail involvement affects 80–90% of patients with plaque psoriasis, and is even
more prevalent in patients with psoriatic arthritis. This review is the result of a systemic …

Nail psoriasis is common, occurring in up to half of patients with psoriasis and in 90% of
patients with psoriatic arthritis. Left untreated, it may progress to debilitating nail disease …

Abstract Background Although cyclosporin (CyA) has been in use in psoriasis for more than
20 years, there is still controversy regarding treatment strategy, monitoring of kidney function …

Importance Nail psoriasis can be difficult to treat and has a significant effect on quality of life.
Relatively few controlled trials evaluating treatments for nail psoriasis have been published …

Psoriasis is a chronic inflammatory skin condition that affects approximately 2% of the
population. Up to 50% of patients with psoriasis have concurrent nail psoriasis, with a …

Objective An estimated 40–50% of patients with psoriasis (PsO) have psoriatic nail disease,
which is associated with and directly contributes to a greater clinical burden and worse …

Background Tofacitinib is an oral Janus kinase inhibitor. Efficacy and safety of tofacitinib in
patients with moderate-to-severe plaque psoriasis have been demonstrated. Objective We …

Background Nail psoriasis (NP) has a prevalence that ranges from 10 to 82% among
patients with psoriasis (PsO) and is one of the most common difficult to treat site of psoriasis …